JP2022534159A5 - - Google Patents
Info
- Publication number
- JP2022534159A5 JP2022534159A5 JP2021541224A JP2021541224A JP2022534159A5 JP 2022534159 A5 JP2022534159 A5 JP 2022534159A5 JP 2021541224 A JP2021541224 A JP 2021541224A JP 2021541224 A JP2021541224 A JP 2021541224A JP 2022534159 A5 JP2022534159 A5 JP 2022534159A5
- Authority
- JP
- Japan
- Prior art keywords
- melatonin
- carboxylic acid
- dosage form
- powder
- hydrogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962794159P | 2019-01-18 | 2019-01-18 | |
| US62/794,159 | 2019-01-18 | ||
| PCT/US2020/014086 WO2020150605A1 (en) | 2019-01-18 | 2020-01-17 | Solid micronized melatonin composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022534159A JP2022534159A (ja) | 2022-07-28 |
| JP2022534159A5 true JP2022534159A5 (enExample) | 2023-01-20 |
Family
ID=71610353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021541224A Pending JP2022534159A (ja) | 2019-01-18 | 2020-01-17 | 微細化した固形メラトニン組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20200230059A1 (enExample) |
| EP (1) | EP3911315A4 (enExample) |
| JP (1) | JP2022534159A (enExample) |
| CN (1) | CN113490491A (enExample) |
| AU (1) | AU2020209940A1 (enExample) |
| BR (1) | BR112021013976A2 (enExample) |
| CA (1) | CA3126413A1 (enExample) |
| MX (1) | MX2021008623A (enExample) |
| WO (1) | WO2020150605A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4090315A1 (en) * | 2020-01-17 | 2022-11-23 | Société des Produits Nestlé S.A. | Dosage form with sustained release melatonin pellets |
| CN117500495A (zh) * | 2021-03-22 | 2024-02-02 | 菲尔提斯印度私人有限公司 | 含褪黑素和羧酸化合物的用于增强抗氧化性以增加作物产量的农业组合物 |
| AU2022288129A1 (en) * | 2021-06-09 | 2024-01-18 | Agb-Pharma Ab | Melatonin formulation in solid dosage form |
| WO2024079125A1 (en) | 2022-10-14 | 2024-04-18 | Société des Produits Nestlé S.A. | Sustained release melatonin compositions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9532952B2 (en) * | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
| WO2012103411A2 (en) * | 2011-01-28 | 2012-08-02 | Zx Pharma, Llc | Controlled-release melatonin composition and related methods |
| DK2949322T3 (en) * | 2014-05-28 | 2018-07-23 | Valpharma S P A | FORMULATION FOR ORAL ADMINISTRATION COMPREHENSIVE MELATONIN IN STABLE FORM AND PROCEDURE FOR PREPARING THEREOF |
| ES2684414B1 (es) * | 2017-03-31 | 2019-12-11 | Laboratorios Vinas S A | Composición galénica, para uso oral, que comprende melatonina micronizada y una sal de zinc y método y uso correspondientes |
-
2020
- 2020-01-17 CN CN202080009397.4A patent/CN113490491A/zh active Pending
- 2020-01-17 US US16/746,451 patent/US20200230059A1/en not_active Abandoned
- 2020-01-17 US US17/423,705 patent/US20220079921A1/en not_active Abandoned
- 2020-01-17 WO PCT/US2020/014086 patent/WO2020150605A1/en not_active Ceased
- 2020-01-17 BR BR112021013976-1A patent/BR112021013976A2/pt not_active Application Discontinuation
- 2020-01-17 AU AU2020209940A patent/AU2020209940A1/en not_active Abandoned
- 2020-01-17 CA CA3126413A patent/CA3126413A1/en active Pending
- 2020-01-17 EP EP20740875.8A patent/EP3911315A4/en active Pending
- 2020-01-17 MX MX2021008623A patent/MX2021008623A/es unknown
- 2020-01-17 JP JP2021541224A patent/JP2022534159A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022534159A5 (enExample) | ||
| RU2013127593A (ru) | Быстродиспергирующиеся гранулы, перорально распадающиеся таблетки и способы | |
| CN102716097A (zh) | 控制口腔崩解片药物释放速率的方法 | |
| FI3746126T3 (fi) | Menetelmiä ja koostumuksia uniapnean tai pelkän kuorsauksen hoitamiseksi | |
| CN101069675A (zh) | 用于减轻痉挛状态的体征和症状的方法 | |
| MXPA06002023A (es) | Nueva formulacion de ropinirol. | |
| JP2020128442A (ja) | 酢酸亜鉛水和物錠及びその製造方法 | |
| JP2013253093A (ja) | ローラーコンパクターを使用した多微粒子の製造方法 | |
| JP2022534159A (ja) | 微細化した固形メラトニン組成物 | |
| CN101856338A (zh) | 枸橼酸钾缓释丸剂 | |
| JP5713421B1 (ja) | 口腔内崩壊錠 | |
| ES2643287T3 (es) | Formulaciones de disgregación oral de lacosamida | |
| US12201729B2 (en) | Process for mesalazine solid formulations | |
| KR20090086128A (ko) | 메만틴 약학 조성물 | |
| CN103127023A (zh) | 一种盐酸度洛西汀肠溶片及其制备方法 | |
| CN102648915A (zh) | 一种治疗或预防神经病理性疼痛的药物组合物 | |
| JP6227352B2 (ja) | アナグリプチン又はその塩を含有する固形製剤 | |
| CN102232934B (zh) | 一种脉冲微丸及含其的脉冲口腔崩解片,制备方法和用途 | |
| CN201179204Y (zh) | 布洛伪麻缓释胶囊 | |
| Malpure et al. | Effect of rupturable and erodible polymers in the outer shell of press coated tablet | |
| CN114869908A (zh) | 一种辅助促进睡眠的药物制剂及其制备方法 | |
| Krishna et al. | Formulation and evaluation of pulsatile drug delivery system of flurbiprofen | |
| CN100588402C (zh) | 天然产物桑皮苷的新用途 | |
| CN103006656A (zh) | 一种镇咳祛痰的复方化学药物 | |
| CN115531326A (zh) | 一种卡巴拉汀微片及其制备方法 |